(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0.70%40.45B | 35.52%33.4B | 74.95%24.79B | 117.77%11.45B | 428.69%40.17B | 536.40%24.65B | --14.17B | --5.26B | 136.31%7.6B | 60.21%3.87B |
Operating income | 0.70%40.45B | 35.52%33.4B | 74.95%24.79B | 117.77%11.45B | 428.69%40.17B | 536.40%24.65B | 14.17B | 5.26B | 136.31%7.6B | 60.21%3.87B |
Cost of sales | -1.43%-6.1B | ---- | -42.50%-3.2B | ---- | -106.69%-6.01B | ---- | ---2.25B | ---- | -54.11%-2.91B | ---- |
Operating expenses | -1.43%-6.1B | -25.20%-4.46B | -42.50%-3.2B | -51.01%-1.17B | -106.69%-6.01B | -97.04%-3.57B | -2.25B | -773.63M | -54.11%-2.91B | -36.18%-1.81B |
Gross profit | 0.57%34.35B | 37.26%28.94B | 81.07%21.58B | 129.29%10.28B | 628.57%34.15B | 921.69%21.08B | 11.92B | 4.48B | 253.27%4.69B | 89.53%2.06B |
Selling expenses | -16.32%-33.77M | -39.91%-27M | -80.19%-21.77M | -36.05%-7.91M | -41.71%-29.03M | -70.62%-19.3M | ---12.08M | ---5.81M | 0.14%-20.49M | 22.13%-11.31M |
Administrative expenses | -56.62%-641.18M | -101.41%-490.8M | -106.24%-361.77M | 18.08%-112.27M | 14.37%-409.37M | 21.88%-243.68M | ---175.41M | ---137.05M | -15.28%-478.06M | -17.48%-311.91M |
Research and development expenses | -13.75%-30.38M | -14.07%-20.94M | -27.13%-14.63M | -37.54%-7.81M | -41.84%-26.7M | -23.54%-18.36M | ---11.51M | ---5.68M | 22.43%-18.83M | 18.46%-14.86M |
Profit from asset sales | ---- | --7.81M | ---- | --11.72K | ---- | ---- | ---- | ---- | ---- | --1.35M |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | -1,360.51%-898.98M | ---- | ---586.02M | ---- | ---61.55M |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | -1,360.51%-898.98M | ---- | ---586.02M | ---- | ---61.55M |
Impairment and provision | -950.67%-650.32M | -2.78%-32.38M | 312.77%89.59M | 1,386.41%77.2M | -103.75%-61.9M | -217.38%-31.51M | ---42.11M | ---6M | 3,320.62%1.65B | -320.75%-9.93M |
-Other impairment is provision | -950.67%-650.32M | -2.78%-32.38M | 312.77%89.59M | 1,386.41%77.2M | -103.75%-61.9M | -217.38%-31.51M | ---42.11M | ---6M | 3,320.62%1.65B | -320.75%-9.93M |
Special items of operating profit | -45.38%702.92M | -45.20%3.27B | -65.70%336.8M | -7.94%1.47B | 168.91%1.29B | 485.25%5.97B | --981.92M | --1.59B | 345.27%478.59M | 3,462.09%1.02B |
Operating profit | -3.49%33.7B | 23.13%31.59B | 70.70%21.61B | 120.48%11.67B | 454.06%34.91B | 867.59%25.66B | 12.66B | 5.29B | 914.62%6.3B | 246.83%2.65B |
Financing cost | 49.19%-550.1M | 119.16%92.9M | 60.00%-238.63M | 133.44%81.34M | 26.59%-1.08B | 68.07%-484.86M | ---596.59M | ---243.24M | 19.65%-1.47B | -7.54%-1.52B |
Share of profits of associates | -49.05%3B | ---- | -19.15%2.04B | ---- | 683.12%5.9B | ---- | --2.52B | ---- | 367.17%752.77M | ---- |
Share of profit from joint venture company | --113.72M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of earning before tax | ---- | 4.20%14.44M | ---- | 125.31%252.59K | ---- | 20.19%13.86M | ---- | ---998.08K | ---- | --11.53M |
Earning before tax | -8.72%36.26B | 25.86%31.7B | 60.50%23.41B | 132.76%11.76B | 612.01%39.73B | 2,100.55%25.19B | 14.59B | 5.05B | 629.68%5.58B | 342.60%1.14B |
Tax | -20.47%-10.62B | -65.66%-9.33B | -158.57%-6.93B | -196.16%-3.3B | -541.63%-8.81B | -1,158.67%-5.63B | ---2.68B | ---1.12B | -1,830.02%-1.37B | -316.46%-447.37M |
After-tax profit from continuing operations | -17.04%25.64B | 14.40%22.37B | 38.43%16.48B | 114.80%8.45B | 635.00%30.91B | 2,704.97%19.55B | 11.91B | 3.94B | 474.01%4.21B | 220.37%697.15M |
Earning after tax | -17.04%25.64B | 14.40%22.37B | 38.43%16.48B | 114.80%8.45B | 635.00%30.91B | 2,704.97%19.55B | 11.91B | 3.94B | 474.01%4.21B | 220.37%697.15M |
Minority profit | 163.56%18.37B | 299.39%14.27B | 498.30%10.04B | 488.86%3.58B | 1,151.82%6.97B | 2,035.41%3.57B | --1.68B | --607.7M | -21.20%556.66M | -68.50%167.34M |
Profit attributable to shareholders | -69.60%7.28B | -49.33%8.1B | -36.98%6.45B | 46.49%4.88B | 556.16%23.94B | 2,916.44%15.98B | 10.23B | 3.33B | 299.31%3.65B | 147.71%529.81M |
Basic earnings per share | -71.19%4.44 | -52.96%4.93 | -43.29%3.93 | 32.00%2.97 | 523.89%15.41 | 2,811.11%10.48 | 6.93 | 2.25 | 299.19%2.47 | 148.00%0.36 |
Diluted earnings per share | -71.19%4.44 | -52.96%4.93 | -43.29%3.93 | 32.00%2.97 | 523.89%15.41 | 2,811.11%10.48 | 6.93 | 2.25 | 299.19%2.47 | 148.00%0.36 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data